miércoles, 15 de julio de 2020

First data for Moderna Covid-19 vaccine show an immune response - STAT

First data for Moderna Covid-19 vaccine show an immune response - STAT

Morning Rounds

Shraddha Chakradhar

First data for Moderna Covid-19 vaccine show it spurs an immune response

The first published data from an early-stage trial of Moderna's Covid-19 vaccine show that it led patients to produce neutralizing antibodies, but many experienced minor side effects. Patients who were given the vaccine — called mRNA-1273 — made more antibodies to neutralize SARS-CoV-2 than patients who have recovered from Covid-19, the data show. But the big questions of whether these antibodies will protect against future infection and for how long still remain. Moderna announced that it will be initiating a 30,000-person Phase 3 trial later this month to continue testing its vaccine. Read more from STAT's Matthew Herper and Damian Garde here.

Here's what else is new with the pandemic: 
  • New instructions posted in an obscure HHS document this week are asking hospitals to bypass submitting their Covid-19 data to the CDC and instead to a central database in Washington, according to the New York Times. HHS — and not the CDC — will collect information on hospital beds, ventilator availability and other statistics, a move that government officials shared would streamline data collection. But critics are worried that this central repository could leave the data vulnerable to being manipulated for political gain. 
  • “If we could get everybody to wear a mask right now, I really think in the next four, six, eight weeks, we could bring this epidemic under control,” CDC Director Robert Redfield said during a live webcast yesterday, underscoring the importance of face coverings. His comments accompanied an editorial yesterday in which he and agency colleagues urged universal masking, and a CDC report of a Missouri salon where two stylists who turned out to have Covid-19 didn't infect nearly 140 patrons because all wore masks. 
  • As physicians have increasingly abandoned the familiar stethoscope to examine Covid-19 patients in favor of point-of-care ultrasounds, the writer of a new First Opinion wonders if stethoscopes — which can be unreliable and transmit infection — will become a relic of the past.

No hay comentarios: